Last reviewed: June 7, 2026
Last updated: June 7, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
GLP-1 receptor agonists activate appetite-suppressing pathways in your brain, leading to an average weight loss of 15–22% of starting body weight in clinical trials. Starting GLP-1 therapy requires realistic expectations about timing, side effects, and how your body adapts over the first month. This guide walks you through the actual experience of beginning personalized GLP-1 treatment.
How GLP-1 Medications Work in Your Body
GLP-1 (glucagon-like peptide-1) is a natural hormone your intestines release after eating. GLP-1 receptor agonists mimic this hormone, sending signals to your brain's appetite centers and slowing how fast food leaves your stomach. This combination creates feelings of fullness earlier and reduces cravings between meals. Semaglutide injections, like those from PlexusDx's 503A compounding pharmacies, deliver this effect consistently throughout the week.
The medications also help stabilize blood sugar by prompting your pancreas to release insulin when blood glucose rises. This dual action—appetite reduction plus metabolic support—is why GLP-1 therapy produces sustained weight loss rather than temporary restriction. Most people begin noticing reduced hunger within 3–5 days of their first injection, though the full effect builds over weeks.
Timeline: What Happens Week by Week on GLP-1
Days 1–3: You may feel no change immediately, and that's normal. Your body is beginning to respond to the medication, but appetite suppression usually takes several days to become noticeable. During this window, some people report mild nausea or fatigue, while others feel no side effects at all. Staying hydrated and eating small, balanced meals supports your body's adjustment.
Week 2–3: Most patients report their first appetite changes—less interest in snacks, smaller portion sizes at meals, and reduced cravings for sugar or carbohydrates. Energy levels often stabilize by this point, and nausea (if present) typically decreases. You may notice the first 3–5 pounds of weight loss, though some of this is water weight as your appetite drops.
Week 4+: The appetite suppression becomes consistent and predictable. By the end of your first month on semaglutide or tirzepatide, your new eating patterns feel more automatic. PlexusDx patients often report their dose may need adjustment based on response, but your monthly price remains flat at $149–$189, no matter your dose level.
Common Side Effects and How to Manage Them
Nausea is the most frequent side effect, occurring in 20–40% of people in the first two weeks. Eating smaller, protein-forward meals and avoiding greasy or overly sweet foods reduces nausea severity. Ginger tea, staying hydrated, and taking your injection at night (so you sleep through the adjustment) help many patients. Nausea typically subsides by week 3 or 4 as your body adapts.
Constipation affects about 25% of GLP-1 users because slower stomach emptying means less frequent bowel movements. Drinking 8–10 glasses of water daily, eating fiber-rich vegetables, and gentle movement like walking prevent or ease constipation. If it persists beyond two weeks, your PlexusDx provider can recommend over-the-counter supports or discuss dosing timing.
Fatigue, headaches, and mild dizziness occur in some patients during the first week but resolve quickly in most cases. These symptoms often signal dehydration or low blood sugar, so consistent eating and drinking prevent them. Rare serious side effects (pancreatitis, gallbladder issues) occur in less than 1% of users; contact your provider immediately if you experience severe abdominal pain.
Maximizing Results: Nutrition and Lifestyle With GLP-1
GLP-1 medications suppress appetite, but they don't choose what you eat—you do. Pairing your semaglutide or tirzepatide injection with protein-rich foods (chicken, fish, eggs, Greek yogurt) maximizes satiety and preserves muscle mass during weight loss. Whole grains, non-starchy vegetables, and healthy fats (nuts, olive oil, avocado) create meals that keep you satisfied longer and support steady energy.
Physical activity amplifies weight loss results. While GLP-1 medications reduce hunger and food intake, exercise builds lean muscle and accelerates fat loss. Aim for 150 minutes of moderate activity weekly (brisk walking, cycling, swimming) plus two strength sessions. Many PlexusDx patients find they naturally move more once appetite control gives them stable energy.
Sleep quality and stress management matter too. Poor sleep disrupts hunger hormones and increases cravings, partly offsetting GLP-1's effects. Aiming for 7–9 hours nightly and practicing stress-reduction (meditation, yoga, time outdoors) helps your body respond better to treatment. PlexusDx's approach treats weight loss as a multi-system change, not just medication.
Genetic Testing for Personalized GLP-1 Response
Not everyone responds identically to GLP-1 therapy—genetic variation in peptide pathways explains much of this difference. PlexusDx's Precision Peptide Genetic Test ($99 after your first month of treatment) analyzes 14 metabolic pathways and 49 peptides to predict how your body will respond to semaglutide, tirzepatide, or dual-compound options. Key variants like GLP1R rs6923761 and GIPR rs1800437 directly influence GLP-1 receptor sensitivity.
Testing also examines variants in satiety genes (MC4R rs17782313) and fat metabolism (FTO rs9939609), revealing why some people feel fuller faster while others need precise timing adjustments. With this genetic insight, your PlexusDx provider personalizes your medication choice and dosing strategy, reducing trial-and-error. Over 150 genetic insights from your results guide long-term treatment success.
Cost and Access: PlexusDx's Transparent GLP-1 Pricing
PlexusDx compounded semaglutide injections start at $149 per month with flat monthly pricing across all dose levels—your dose may need to go up, but your price won't. No insurance is required, no membership fees apply, and PlexusDx serves all 50 states. HSA and FSA accounts cover the treatment, lowering your effective out-of-pocket cost if you have these accounts.
Patients choosing oral semaglutide pay $249 per month, while tirzepatide injections begin at $249 monthly. All medications come from licensed 503A compounding pharmacies, ensuring quality and consistency. If genetic testing reveals you'd respond better to a dual-compound approach, PlexusDx's GLP-Squared Injection combines semaglutide and tirzepatide starting at $249 per month—again, a flat price regardless of your dose escalation.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
When will I start losing weight on GLP-1?
Most people see their first appetite changes within 3–5 days, with measurable weight loss by week 2–3. Initial loss includes water weight and fat, with average monthly losses of 2–4 pounds once side effects settle. PlexusDx patients on semaglutide injections report consistent results by month 2, especially when combined with structured nutrition.
How much weight can I expect to lose?
Clinical trials show GLP-1 users lose 15–22% of their starting body weight over 12–18 months. A person starting at 250 pounds might lose 38–55 pounds. Results depend on adherence, diet quality, exercise, and individual metabolism—which is why PlexusDx offers genetic testing to predict your response trajectory.
Is PlexusDx's semaglutide the same as brand-name Ozempic?
PlexusDx's semaglutide is a compounded version made by licensed 503A pharmacies, containing the same active ingredient as Ozempic but at a lower cost ($149/mo vs. $900+). Compounded formulations are not FDA-approved but are legal, regulated, and prescribed widely. Your provider ensures quality and sterility.
What if I have nausea or other side effects I can't tolerate?
Nausea and constipation are manageable with small meals, hydration, and timing adjustments in most cases. If side effects persist beyond week 4 or are severe, your PlexusDx provider can lower your dose or switch you to oral semaglutide ($249/mo), which some patients tolerate better. Never stop medication without guidance.
How does the Precision Peptide Genetic Test help my treatment?
The test ($99 after month 1) analyzes variants in GLP1R, GIPR, MC4R, and FTO genes, predicting whether you'll be a strong responder to GLP-1 alone or need tirzepatide or a dual compound for optimal results. Testing reveals your genetic satiety profile and metabolic capacity, letting PlexusDx tailor your therapy from the start.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Do You Have to Diet on Tirzepatide? Exploring Your Weight Loss Journey
Can Pre-Diabetics Take Mounjaro? How Tirzepatide Supports Prevention